The
following potentially dilutive securities were excluded from the computation of diluted net loss per share as their effect would have
been anti-dilutive for the periods presented.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Nine months ended September 30,
2021
2020
Stock options, unvested RSAs, unvested RSUs and purchase warrants
844,394
814,285
Senior convertible notes and convertible related party LOC, plus related accrued interest
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.